“…Mutations T670I and V654A were introduced into the wild-type structure of KIT/imatinib complex using the Biopolymer module of Insight II (v. 2001, Accerlys Inc., San Diego, CA, USA) by swapping the mutant residue into the specific site, according to a dedicated and well-validated procedure (Reyes and Kollman, 2000;Pricl et al, 2005). To set up each resulting complex for the simulation, we adopted the following ansatz: first, each complex was immersed in a sphere of TIP3P water molecules (Jorgensen et al, 1983). To achieve electroneutrality, a suitable number of counterions were added, in the positions of largest electrostatic potential, as determined by the module Cion within AMBER 7.0.…”